Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study

Regulatory bodies in The Philippines, Sri Lanka, and India require post-marketing surveillance to provide additional safety data on Rotarix™ in real-life settings. In such studies conducted in The Philippines (November 2006 to July 2012; NCT00353366), Sri Lanka (November 2008 to August 2009; NCT0077...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Bravo, Lulu, Chitraka, Amarjeet, Liu, Aixue, Choudhury, Jaydeep, Kumar, Kishore, Berezo, Lennie, Cimafranca, Leonard, Chatterjee, Pallab, Garg, Pankaj, Siriwardene, Prasanna, Bernardo, Rommel, Mehta, Shailesh, Balasubramanian, Sundaram, Karkada, Naveen, Htay Han, Htay
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896787/
https://ncbi.nlm.nih.gov/pubmed/25424932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29280
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars